Isomorphic Labs, a startup from DeepMind and Alphabet, has announced strategic research collaborations with Eli Lilly and Novartis for AI-driven drug discovery. The collaborations are potentially worth nearly $3 billion, with upfront payments of $82.5 million. The company aims to revolutionize medicine with its AI-first approach and has been working on discovering drugs for ALS, liver disease, and cancer. This move highlights the increasing role of AI in drug development and the potential for significant real-world impact.
A look at Insilico's big early bet on #AI drug discovery from @ReedAlbergotti at @semafor, and how the Company has continued to embrace the latest tech breakthroughs like #AlphaFold to discover new targets and treatments for both #disease and #aging. https://t.co/BxLLRtF9dF
Our CEO @DemisHassabis spoke to the @FT about our Ai-first drug discovery ambitions and recently announced pharma collaborations with @EliLillyandCo and @Novartis #AI #drugdiscovery #machinelearning https://t.co/5gtMSrt2d5
Read reflections on discovering new drugs using cutting-edge AI with @IsomorphicLabs, by @FionaHMarshall President of Biomedical Research @Novartis #AI #drugdiscovery #machinelearning https://t.co/elZwlXERjG
A really insightful article from about the future of drug discovery, and the fundamental role of AI in it, from our partners @FionaHMarshall and @Novartis. Exciting to be building this future together! https://t.co/TWInP94z6W
Isomorphic Inks Strategic Partnerships with Eli Lilly and Novartis for AI-Driven Drug Discovery #AI #AItechnology #AIdrivendrugdiscovery #Alphabet #AlphaFold2 #AlphaFoldversion #artificialintelligence #CEO #Chagasdisease #combinedvalue #DeepMind https://t.co/kweLUZqiBC https://t.co/u3uVWvzTd9
Five #predictions (+1) for the #AI drug discovery industry for 2024 from Insilico founder and co-CEO @biogerontology in @Forbes, including continued consolidation, transition to asset licensing, and growing role of @nvidia. https://t.co/auCbWTvctz
Isomorphic inks deals with Eli Lilly and Novartis for drug discovery https://t.co/csoWlrpcXg Visit https://t.co/l8fNQzV9nN for more AI news. #AI #artificialintelligence #biotechnology #alphafold #deepmind #elilil
1/ Isomorphic Labs, a start-up from Deepmind and Alphabet, aims to establish AI in medicine, particularly in drug development.
🚨 AI in medicine could be more lucrative than just the next LLM - @GoogleDeepMind and Alphabet's latest AI startup, @IsomorphicLabs, aims to use AI in medicine, specifically in drug development - The company has now announced strategic research collaborations with… https://t.co/3XRQJld5pM
DeepMind spin-out @IsomorphicLabs has signed two deals with pharma giants @EliLillyandCo and @Novartis to discover new drugs, which could lead to billions in profit for the company. https://t.co/c7DE0PnyIk
Isomorphic signs drug discovery deals with Eli Lilly and Novartis https://t.co/c7DE0PnyIk
Exclusive: Alphabet's Isomorphic inks first pharma deals with Eli Lilly and Novartis for $83M upfront, $2.9B in milestones https://t.co/VyUL2vHxpb
AI drug discovery startup Isomorphic Labs partners with Eli Lilly and Novartis https://t.co/uzRn4ap8we
Something to pay attention to: Isomorphic signs agreements with Eli Lilly and Novartis to discover drugs #AI https://t.co/EIU89LHIEI
Isomorphic Labs, a subsidiary of Alphabet Inc., said it entered into strategic research collaboration agreements with Novartis and Eli Lilly https://t.co/5gbI2BY55i
DeepMind spinout Isomorphic Labs partners with Eli Lilly and Novartis on AI-based drug discovery, receiving $82.5M upfront and $2.9B in performance incentives (@kyle_l_wiggers / TechCrunch) https://t.co/sqFpAzJroj 📫 Subscribe: https://t.co/OyWeKSRpIM https://t.co/5118xFeI3X
Isomorphic inks deals with Eli Lilly and Novartis for drug discovery: https://t.co/WP4QcW2WfX by TechCrunch #infosec #cybersecurity #technology #news
Isomorphic inks deals with Eli Lilly and Novartis for drug discovery https://t.co/zYDyQEJhD6
"Wow, Isomorphic Labs strikes gold with Eli Lilly and Novartis for drug discovery. The London-based company is set to revolutionize meds with AI. Check out the scoop here: https://t.co/6AiwEuvb1i"
I’m excited to share that we’re entering a strategic research collaboration with Isomorphic Labs to use state-of-the-art #AI technologies—including the next-gen model of AlphaFold—to discover novel small molecule therapeutics for select biological targets. https://t.co/yUg4PU1Mau https://t.co/P8GHzi07li
Thrilled to announce @IsomorphicLabs collaborations with @EliLillyandCo & @Novartis potentially worth nearly $3 billion. These target-based programs represent just the start of the phenomenal real-world impact AI will have in accelerating drug discovery: https://t.co/Nz7eY1pZ14
Newsflash! We are now partnered with @EliLillyandCo & @Novartis in deals worth up to nearly $3 billion to develop new medicines against challenging targets. This is showtime for the AI tech we’ve been building for the last two years. Let’s go! https://t.co/Sas9PuspM8 #ai #JPM24 https://t.co/sIQNJm7akM
Andrew Dunn with a #JPM24 exclusive Exclusive: Alphabet's Isomorphic inks first pharma deals with Eli Lilly and Novartis for $83M upfront, $2.9B in milestones https://t.co/f2eRtr8kLX
Insitro, biotech AI’s quiet unicorn, unveils efforts in ALS, liver disease, and cancer at JPM An exclusive from @matthewherper https://t.co/b0wHDCSaar
We are thrilled to announce our pharma collaborations with @EliLillyandCo & @Novartis, which combined are potentially worth nearly $3 billion and testament to the promise of our AI-first approach to drug design. Read more here: https://t.co/OvhQeE2Lj4 #AI #drugdiscovery https://t.co/GHJONt4ItN
Tough thing about AI/biotech. AI is hot. But is drug development? Insitro, one of biotech's big AI names, has been quiet. At #JPM24, the company is revealing work on ALS, liver disease, and cancer --and a new CMO. I got an early look. https://t.co/2hAtRGzixE
BREAKING: Alphabet's closely watched AI bio Isomorphic Labs has inked its 1st pharma deals, CEO @demishassabis told me. Eli Lilly and Novartis will pay $82.5 million upfront along with $2.9B in pot'l milestones to discover drugs. Scoop 🔗: https://t.co/6fT7aM2mRU